August 28th 2025
ESC 2025: The first global investigation of evidence for the potential positive connection is encouraging, but more research is needed to understand causality.
IDWeek 2023: New Data Provide Closer Look at Real-World Utilization of Cabotegravir for HIV PrEP
October 15th 2023IDWeek 2023. New study found just slightly more than half of prescriptions for cabotegravir for HIV PrEP resulted in at least 1 injection, suggesting limitations in use and access to the injectable HIV integrase inhibitor.